Skip to content
10-Q

Quarterly Report

PURE Bioscience, Inc. PURE

0001493152-26-028691

← back to feed
Filed
Jun 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Jun 15, 2026 130.02M sh
Shares Diluted Q3 2026 · Apr 30, 2026 110.83M sh
Shares Diluted Q3 2026 · Apr 30, 2026 111.54M sh
Shares Diluted Q3 2026 · Apr 30, 2025 111.86M sh
Shares Diluted Q3 2026 · Apr 30, 2025 111.86M sh
Operating Cash Flow Q3 2026 · Apr 30, 2026 −$1.32M
Operating Cash Flow Q3 2026 · Apr 30, 2025 −$1.56M
Cash And Equivalents Q3 2026 · Apr 30, 2026 $983K
Cash And Equivalents Q3 2026 · Jul 31, 2025 $334K
Cash And Equivalents Q3 2026 · Apr 30, 2025 $540K
Stockholders Equity Q3 2026 · Apr 30, 2026 −$5.84M
Stockholders Equity Q3 2026 · Jan 31, 2026 −$6.27M
Stockholders Equity Q3 2026 · Jul 31, 2025 −$5.12M
Stockholders Equity Q3 2026 · Apr 30, 2025 −$4.81M
Stockholders Equity Q3 2026 · Jan 31, 2025 −$4.27M
Stockholders Equity Q3 2026 · Jul 31, 2024 −$2.86M
Current Liabilities Q3 2026 · Apr 30, 2026 $3.65M
Current Liabilities Q3 2026 · Jul 31, 2025 $938K
Total Liabilities Q3 2026 · Apr 30, 2026 $7.4M
Total Liabilities Q3 2026 · Jul 31, 2025 $6.17M
Current Assets Q3 2026 · Apr 30, 2026 $1.55M
Current Assets Q3 2026 · Jul 31, 2025 $1.05M
Total Assets Q3 2026 · Apr 30, 2026 $1.56M
Total Assets Q3 2026 · Jul 31, 2025 $1.06M
Eps Diluted Q3 2026 · Apr 30, 2026 −$0.01
Eps Diluted Q3 2026 · Apr 30, 2026 −$0.02
Eps Diluted Q3 2026 · Apr 30, 2025 −$0.01
Eps Diluted Q3 2026 · Apr 30, 2025 −$0.02
Eps Basic Q3 2026 · Apr 30, 2026 −$0.01
Eps Basic Q3 2026 · Apr 30, 2026 −$0.02
Eps Basic Q3 2026 · Apr 30, 2025 −$0.01
Eps Basic Q3 2026 · Apr 30, 2025 −$0.02
Sga Expense Q3 2026 · Apr 30, 2026 $708K
Sga Expense Q3 2026 · Apr 30, 2026 $2.3M
Sga Expense Q3 2026 · Apr 30, 2025 $776K
Sga Expense Q3 2026 · Apr 30, 2025 $2.53M
Rd Expense Q3 2026 · Apr 30, 2026 $79K
Rd Expense Q3 2026 · Apr 30, 2026 $239K
Rd Expense Q3 2026 · Apr 30, 2025 $91K
Rd Expense Q3 2026 · Apr 30, 2025 $243K
Net Income Q3 2026 · Apr 30, 2026 −$624K
Net Income Q3 2026 · Apr 30, 2026 −$1.87M
Net Income Q3 2026 · Apr 30, 2025 −$580K
Net Income Q3 2026 · Apr 30, 2025 −$2.07M
Operating Income Q3 2026 · Apr 30, 2026 −$518K
Operating Income Q3 2026 · Apr 30, 2026 −$1.58M
Operating Income Q3 2026 · Apr 30, 2025 −$584K
Operating Income Q3 2026 · Apr 30, 2025 −$1.94M
Gross Profit Q3 2026 · Apr 30, 2026 $269K
Gross Profit Q3 2026 · Apr 30, 2026 $957K
Gross Profit Q3 2026 · Apr 30, 2025 $283K
Gross Profit Q3 2026 · Apr 30, 2025 $835K
Cost Of Revenue Q3 2026 · Apr 30, 2026 $237K
Cost Of Revenue Q3 2026 · Apr 30, 2026 $701K
Cost Of Revenue Q3 2026 · Apr 30, 2025 $208K
Cost Of Revenue Q3 2026 · Apr 30, 2025 $603K
Revenue Q3 2026 · Apr 30, 2026 $506K
Revenue Q3 2026 · Apr 30, 2026 $1.66M
Revenue Q3 2026 · Apr 30, 2025 $491K
Revenue Q3 2026 · Apr 30, 2025 $1.44M